# Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation(BM-MSC) for Kienbock's Disease

> **NCT02646007** · PHASE1 · UNKNOWN · sponsor: **Royan Institute** · enrollment: 30 (estimated)

## Conditions studied

- Kienböck's Disease

## Interventions

- **BIOLOGICAL:** BM-MSC transplantation

## Key facts

- **NCT ID:** NCT02646007
- **Lead sponsor:** Royan Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-11
- **Primary completion:** 2018-11
- **Final completion:** 2018-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2016-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02646007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02646007, "Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation(BM-MSC) for Kienbock's Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02646007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*